Read Our Recent News
NanoMab To Initiate FIH for 99mTc-NM-01 at SGH
Date: Feb 27th, 2018 NanoMab To Initiate FIH for 99mTc-NM-01 at SGH Shanghai, China, February 27th, 2018. NanoMab announced that it has decided to initiate FIH with NM-01, which is the company’s non-small cell lung cancer (NSCLC) program. The kick off meeting was held at Shanghai General Hospital (SGH). The primary objective of this study is to evaluate safety, tolerability and pharmacokinetics of NM-01. 99mTc-NM-01 is a camelid single domain antibody-based imaging agent for the non-invasive and whole body assessment of PD-L1 [...]
Privacy Policy and Website Terms of Use
Nano-Mab’s Website Privacy Policy We ask that you read this privacy policy carefully as it contains important information on who we are, how and why we collect, store, use and share personal information, your rights in relation to your personal information and on how to contact us and supervisory authorities in the event you have a complaint. Who we are NanoMab collects, uses and is responsible for certain personal information about you. When we do so we are regulated under the General Data Protection [...]